Search results
Duke Box 2631, Durham, NC 27710. +1 919 681 2239. anixon@duke.edu. Overview. Andrew Nixon, PhD, MBA (Professor of Medicine) is Director of the Phase I Biomarker Laboratory, which brings together clinical, translational and basic research to pursue the development of novel biomarkers defining mechanisms of sensitivity, resistance, and toxicity ...
- Andrew Nixon Duke Lab
Dr. Andrew Nixon is a Professor of Medicine at Duke...
- Scholars@Duke profile
Andrew Nixon, PhD, MBA (Professor of Medicine) is Director...
- Duke University School of Medicine
(919) 613-7883. anixon@duke.edu. Professor in Medicine. 133...
- Andrew Nixon Duke Lab
Apr 1, 2024 · Andrew Nixon, PhD, MBA (Professor of Medicine) is Director of the Phase I Biomarker Laboratory, which brings together clinical, translational and basic research to pursue the development of novel biomarkers defining mechanisms of sensitivity, resistance, and toxicity to given therapeutic drug classes, particularly anti-angiogenic agents.
Andrew B Nixon. Professor of Medicine, Duke University. Verified email at duke.edu. Oncology Biomarker Development. Title. Sort. Sort by citations Sort by year Sort by title. Cited by.
Member of the Duke Cancer Institute · 1998 - Present Duke Cancer Institute, Institutes and Centers Previous Appointments & Affiliations Professor in Medicine · 2019 - 2020 Medicine, Medical Oncology , Medicine
